Biosimilar User Fees Discounted To Begin Second Round

 
• By Derrick Gingery
  
FDA entrance sign 2016
Biosimilar application fees will drop significantly in fiscal year 2018.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics